Advanced Oxygen Therapy Inc.

Advanced Oxygen Therapy Inc. (AOTI) is a medical technology company specializing in innovative, non-invasive wound care solutions for chronic and acute wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers. The company's flagship product, Topical Wound Oxygen (TWO2®) therapy, delivers cyclical-pressure oxygen with humidification to promote durable healing through enhanced tissue diffusion, edema reduction, and neovascularization. AOTI's product portfolio includes the Extremity Chamber for larger limbs, the Multi-Patch for targeted oxygen delivery, and the NEXA™ NPWT System for negative pressure wound therapy. With clinical evidence demonstrating 88% reduction in hospitalizations and 71% reduction in amputations, AOTI enables at-home treatment delivery supported by telehealth services. The company has delivered over 1 million home treatments and received an A-grade recommendation from the American Diabetes Association for diabetic foot ulcer treatment.